inv

Investors

Our investor proposition

GSK is a science-led global healthcare company that aims to deliver growth and improving returns to shareholders through the development of innovative pharmaceutical, vaccine and consumer healthcare products.

Key information

New GSK Investor update

Emma Walmsley, CEO, and other members of CET hosted a virtual investor update on Wednesday 23 June. The update provided a clear view of the strategy for New GSK, its outlook for growth and the opportunities we see for shareholder value creation. Find out more

Latest information

team 3

London

NYSE

Q1 2021 results
We released our first quarter results on Wednesday 28 April. Find out more

LSE price updated every 15 minutes. Timezone BST

NYSE price updated every 20 minutes. Timezone EST

Annual Report 2020

We published our annual-report-2020  on 09 March 2021. View the summary and download the full report or individual sections.

Sign up for announcements

sign up to receive email notifications when we publish a stock exchange announcement.